QTMeds

Drug Database Monograph

UPLIZNA 100 mg

PENDING REVIEW

Active Ingredient: INEBILIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 60878038

← Back to Prescription Analyzer